Get started
Author

Amadou Niangaly

A Field Trial to Assess a Blood-Stage Malaria Vaccine
2011 · Mahamadou A. Thera, Ogobara K. Doumbo, et al. · New England Journal of Medicine · 375
Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
2017 · Mahamadou S Sissoko, Sara A Healy, et al. · The Lancet Infectious Diseases · 309
Reappraisal of known malaria resistance loci in a large multicenter study
2014 · Malaria Genomic Epidemiology Network, Kirk A Rockett, et al. · Nature Genetics · 222
PDF
Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development
2009 · Shannon L. Takala, Drissa Coulibaly, et al. · Science Translational Medicine · 191
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
2008 · Mahamadou A. Thera, Ogobara K. Doumbo, et al. · PLoS ONE · 176
PDF
Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study
2018 · Carolyne M Ndila, Sophie Uyoga, et al. · The Lancet Haematology · 108
PDF
Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?
2018 · Karthigayan Gunalan, Amadou Niangaly, et al. · Trends in Parasitology · 100
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia
2017 · Geraldine M Clarke, Kirk Rockett, et al. · eLife · 92
Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications
2012 · Amed Ouattara, Shannon Takala-Harrison, et al. · The Journal of Infectious Diseases · 90
PDF
Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali
2017 · Amadou Niangaly, Karthigayan Gunalan, et al. · American Journal of Tropical Medicine and Hygiene · 81
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
2021 · Mahamadou S Sissoko, Sara A Healy, et al. · The Lancet Infectious Diseases · 75
Early Interferon‐γ Response againstPlasmodium falciparumCorrelates with Interethnic Differences in Susceptibility to Parasitemia between Sympatric Fulani and Dogon in Mali
2009 · Matthew B. B. McCall, Joost Hopman, et al. · The Journal of Infectious Diseases · 69
PDF
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
2010 · Amed Ouattara, Jianbing Mu, et al. · Malaria Journal · 68
PDF
Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali
2013 · Drissa Coulibaly, Stanislas Rebaudet, et al. · Malaria Journal · 63
PDF
Candidate Polymorphisms and Severe Malaria in a Malian Population
2012 · Ousmane Toure, Salimata Konate, et al. · PLoS ONE · 63
PDF
Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali
2014 · Drissa Coulibaly, Mark A Travassos, et al. · Malaria Journal · 62
PDF
Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
2010 · Mahamadou A. Thera, Ogobara K. Doumbo, et al. · PLoS ONE · 57
PDF
Spatio-Temporal Dynamics of Asymptomatic Malaria: Bridging the Gap Between Annual Malaria Resurgences in a Sahelian Environment
2017 · Drissa Coulibaly, Mark A. Travassos, et al. · American Journal of Tropical Medicine and Hygiene · 50
Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets
2018 · Mark A. Travassos, Amadou Niangaly, et al. · Scientific Reports · 48
PDF
Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
2013 · Matthew B. Laurens, Mahamadou A. Thera, et al. · PLoS ONE · 45
Hemoglobin C Trait Provides Protection From Clinical Falciparum Malaria in Malian Children
2015 · Mark A. Travassos, Drissa Coulibaly, et al. · The Journal of Infectious Diseases · 39
PDF
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
2016 · Mahamadou A. Thera, Drissa Coulibaly, et al. · Malaria Journal · 35
PDF
Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination
2020 · Jason A. Bailey, Andrea A. Berry, et al. · Scientific Reports · 34
PDF
Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure
2019 · Albert E. Zhou, Andrea A. Berry, et al. · mSphere · 31
PDF
PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
2022 · Drissa Coulibaly, Abdoulaye K. Kone, et al. · EClinicalMedicine · 28
Works count: 110
Citation count: 2,903
H-index: 26
I10-index: 43
Year
Topic
Type